Keppra XR

DRUG2 trials

Sponsors

UCB Pharma, UCB BIOSCIENCES, Inc.

Conditions

Epilepsy

Phase 2

Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy

CompletedNCT00961441

UCB BIOSCIENCES, Inc.Epilepsy

Start: 2009-09-30End: 2010-03-31Updated: 2015-08-06

Phase 3

Conversion to Monotherapy Study With Keppra XR for Partial Seizures

CompletedNCT00419094

UCB PharmaEpilepsy

Start: 2007-08-31End: 2009-09-30Updated: 2014-09-05

Related Papers

Levetiracetam extended release for the treatment of patients with partial-onset seizures: A long-term, open-label follow-up study.

2015-11-254 citations

Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomised, multicentre, historical control study.

2012-04-1823 citations